Optibiotix Health Share Discussion Threads

[parob] 26/1/2017 07:23

Barchart's overall average signal is getting stronger and has moved up to 80% buy:

Fri 13th Jan - 48% buy

Wed 18th Jan - 56% buy

Fri 20th Jan - 72% buy

Weds 25th Jan - 80% buy



The last time I remember this hitting 100% was on the 3rd Nov 2015 - see my post 6504 - the date of the cholesterol patent filing RNS - and we all know what happened to the share price on the 4th Nov & 5th Nov.

[1bokke] 25/1/2017 21:09

This made for interesting reading...https://thetruthaboutcancer.com/healthy-gut-microbiome-cancer-prevention/Not sure how new this is so apologies if it's been seen before.

[elrico] 25/1/2017 20:59

He is filtered bokke.

[elrico] 25/1/2017 20:05

Mouse - Now I am outed you may get a few of those red ones :-)

[onedayrodders] 25/1/2017 19:53

yeah I know what you mean portrush

regards
TW

[elrico] 25/1/2017 19:23

Really ;-)

[mouse20] 25/1/2017 19:15

Elrico - that's funny - and it got 5 ticks!

[elrico] 25/1/2017 19:05

Mouse - I wouldn't get to excited as that was written by me, and so was Tullow....both have been great for me the last 18 months.

mouse2025 Jan '17 - 16:47 - 19210 of 19214 4 0
hxxps://www.research-tree.com/blog/ArticleOffset?blogSeoTitle=our-users-top-bars-eateries-household-goods-and-clothing-retailer-stocks-for-2017&filterByBlogType=true


Optibiotix is another favourite of a Research Tree user.



"Though I don't expect OPTI to gallop early, there are many reasons for it to race ahead in the second half of the year. It has commercial deals with Proctor and Gamble and Tata, which have not been made public by OPTI and there are several products for its cholesterol and hypertension products expected to be launched by spring as well as better than expect sales for its first products using its patented slimbiome used in GoFigure dieting supplements. Its is debt free and cash to see it through for 3 years low fixed cost base which will not rise much and it expects to demerge its Skinbiotix arm in 2017."

Its shares have rallied 24% since the beginning of 2017, so he was wrong about the early gallop.

[riskybusiness1] 25/1/2017 18:23

The lp-ldl probiotic was tested using 0.1g. It is very much possible that the results from the human trials could be increased further with a higher dosage of the probiotic. If this is the case and the lpldl gos prebiotic replicates the threefold increase shown in gut model studies within humans, the novel optibiotic concept that combines the two products will surely take a significant portion of a £60bn side effect ridden statin market...The overlapping value multiplier between the probiotic and optibiotic divisions are becoming clearer. Giving an example to what opti can offer other probiotic companies. The optibiotic divisions ability to target and increase existing probiotics health benefits - creating enhanced versions of products turning £40m+ per year could be worthy of our current mkt cap alone in the next few years. Oh and they are heat resistant and can be placed in multiple food products....

[spike_1] 25/1/2017 18:18

Thanks Someuwin,
The point of sale material 'presentation' is impressive! Simple (uncomplicated), and inexpensive. And physically dominant - good stuff.

[parob] 25/1/2017 17:25

27% cholesterol reduction mentioned again in this article out today - put out by Simon Vane Percy (of their recently appointed PR agency).



"Research to be presented by microbiologist Stephen O’Hara, CEO of OptiBiotix Health, at the Microbiome R&D and Business Collaboration Congress: Asia in Hong Kong on the 1-2 March 2017 will demonstrate that OptiBiotix’s microbiome modulators can increase the growth and biological effect of specific microbial species in the human microbiome.

The oral presentation will show that OptiBiotix’s microbiome modulators have successfully increased the growth and biological effect of multiple species of microbe in human gut models, including their own cholesterol-reducing probiotic, LP-LDL®. By using the microbiome modulator, LPGOS, to increase the growth of LP-LDL® researchers reduced cholesterol as much as 27%."

[mouse20] 25/1/2017 16:47

hxxps://www.research-tree.com/blog/ArticleOffset?blogSeoTitle=our-users-top-bars-eateries-household-goods-and-clothing-retailer-stocks-for-2017&filterByBlogType=true


Optibiotix is another favourite of a Research Tree user.



"Though I don't expect OPTI to gallop early, there are many reasons for it to race ahead in the second half of the year. It has commercial deals with Proctor and Gamble and Tata, which have not been made public by OPTI and there are several products for its cholesterol and hypertension products expected to be launched by spring as well as better than expect sales for its first products using its patented slimbiome used in GoFigure dieting supplements. Its is debt free and cash to see it through for 3 years low fixed cost base which will not rise much and it expects to demerge its Skinbiotix arm in 2017."

Its shares have rallied 24% since the beginning of 2017, so he was wrong about the early gallop.

[elrico] 25/1/2017 14:24

GoFigure on tour in Iceland :-) Filipa and I are in Iceland to promote GoFigure in pharmacies. What a beautiful, cold and friendly country. Thank you to our distributor Heilsa for all their hard work on our behalf.

[nicktopten] 25/1/2017 13:54

Hey Diamond, post away mate , I don't mind at all.... its just impossible to take what you say as any form of investment advice cos it could be cobblers! Who knows?
Hope your correct though and we can call you Diamond Geezer from now on!!

[scotty1] 25/1/2017 13:46

Diamond "If you don't want me to post info"

But you don't post info you just keep posting "news is coming" etc etc.Unless you can back it up with a source,it means diddly as we all know news is coming at some point even TW :))

[judijudi] 25/1/2017 13:39

Spike,
They want dumping!!
imho

[diamond fibre] 25/1/2017 13:39

You lot make me laugh I told you all just a few weeks ago that news was about to break at opti, and even suggested some information may have leak, the shares stood at around 63? At the time. Last week I told you all ITV would rise, so for any one to say I don't know what I am talking about is nonsense. But it's not been all wine and roses as I hold Bt shares and did not see that coming, If you don't want me to post info any more just vote good or bad and if there is more bad than good I will not post any more info, although I will post remarks. DIAMOND.

[spike_1] 25/1/2017 13:34

Well guess what - our own broker (FinnCap) first to bring the price down to 78, and now to 77, even though they were not at the top of the bid i.e. shares being sold by punters were not being bought by them, and there they are right at the bottom of the bid at 72. Nothing like supporting you client - not.

Best wishes - Mike

[elrico] 25/1/2017 12:16

Diamond - with respect, you will not have been given insider info, so whatever you think you know about patents, or whatever and it has come from SOH, I am sure SOH will be happy for you to share, he is a sharing kind of CEO; He has always indicated to me he is happy for me to share and indeed encourages it, probably because it saves paying Wallbroke more fee's :-)

My advice to you is cough or take your medicine and go to bed.